AI/ML Innovations Inc. Announces Annual General Meeting Results

AI/ML Innovations Inc. Announces Annual General Meeting Results

Accesswire

Published

*- All Resolutions Approved -*

*TORONTO, ON / ACCESSWIRE / November 21, 2023 / *AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to report the results of its Annual General Meeting held on November 17, 2023. A total of 13,283,644 common shares were voted by Proxy, representing 21.1% of the Company's issued and outstanding common shares, constituting a quorum. Each of the resolutions presented to the shareholders, as set out in the Information Circular, were approved with a greater than 99 percent vote in favour.

Specifically, the following resolutions were approved:

1. To elect Directors for the ensuing year.

Elected: Tim Daniels; Nick Watters; Randy Duguay; Fabrice Pakin.

2. To appoint auditors for the ensuing year and to authorize the Directors to fix the remuneration of the auditors.

Appointed: Baker Tilly Canada.

3. Approval of the Company's Stock Option Plan.

4. Approval of the Company's Restricted Share/Deferred Share Unit Plan.

The Company's Information Circular is available for download under the Company's profile on SEDAR at https://www.sedarplus.ca/ AI/ML Innovations Inc. wishes to thank all those shareholders who participated in the AGM.

About AI/ML Innovations Inc. https://aiml-innovations.com/

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors
Tim Daniels, Executive Chairman

For more information about AI/ML Innovations:

For detailed information please see AI/ML's website or the Company's filed documents at www.sedar.com.
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.

*Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.*

*SOURCE: *AI/ML Innovations Inc.
View source version on accesswire.com:
https://www.accesswire.com/808011/aiml-innovations-inc-announces-annual-general-meeting-results

Full Article